Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Stahel

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Immunology|September 1, 1992
Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion moleculeE J Derbyshire, R A Stahel, E J Wawrzynczak
Schweizerische Medizinische Wochenschrift|February 23, 2000
[High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich]L M Jost, H P Honegger, R A Stahel
International Journal of Cancer|May 8, 1992
Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common featureD Schmitter, B Lauber, B Fagg, et al.
Onkologie|January 8, 2004
Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neckP Moosmann, F Egli, R A Stahel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1996
Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small-cell lung cancer cellsB A Froesch, R A Stahel, U Zangemeister-Wittke
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancerE J Derbyshire, R A Stahel, E J Wawrzynczak
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upR A Stahel, W Weder, Y Lievens, et al.
International Journal of Cancer|January 15, 1985
Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomasR A Stahel, J A Speak, S D Bernal
British Journal of Cancer|November 1, 1994
Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathwayI A Mórocz, D Schmitter, B Lauber, et al.
Cancer Treatment Reviews|January 1, 1995
High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomasR A Stahel, L M Jost, G Pichert, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Immunology|September 1, 1992
Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion moleculeE J Derbyshire, R A Stahel, E J Wawrzynczak
Schweizerische Medizinische Wochenschrift|February 23, 2000
[High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich]L M Jost, H P Honegger, R A Stahel
International Journal of Cancer|May 8, 1992
Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common featureD Schmitter, B Lauber, B Fagg, et al.
Onkologie|January 8, 2004
Weekly paclitaxel and carboplatin combination chemotherapy in patients with advanced squamous cell carcinoma of the head and neckP Moosmann, F Egli, R A Stahel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1996
Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small-cell lung cancer cellsB A Froesch, R A Stahel, U Zangemeister-Wittke
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Cytotoxic properties of a ricin A chain immunotoxin recognising the cluster-5A antigen associated with human small-cell lung cancerE J Derbyshire, R A Stahel, E J Wawrzynczak
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2010
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upR A Stahel, W Weder, Y Lievens, et al.
International Journal of Cancer|January 15, 1985
Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomasR A Stahel, J A Speak, S D Bernal
British Journal of Cancer|November 1, 1994
Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathwayI A Mórocz, D Schmitter, B Lauber, et al.
Cancer Treatment Reviews|January 1, 1995
High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomasR A Stahel, L M Jost, G Pichert, et al.
Pageof 16